Dec.18, 2012

Organovo, a creator and manufacturer of 3D human tissues for medical research and therapeutic applications, is working together with researchers at Autodesk, Inc., the leader in cloud-based design and engineering software, to create the first 3D design software for bioprinting. No timeline is announced for when the software will be released.

The software, which will be used to control Organovo's NovoGen MMX bioprinter, has the potential to open up bioprinting to a broader group of users. The Organovo's NovoGen MMX bioprinter is the world's only commercial bioprinter and can create 1 millimeter-thick tissues.

Organovo's 3D bioprinting technology is used to create living human tissues that are three-dimensional, architecturally correct, and made entirely of living human cells. The resulting structures can function like native human tissues, and represent an opportunity for advancement in medical research, drug discovery and development, and in the future, surgical therapies and transplantation.

"Autodesk is an excellent partner for Organovo in developing new software for 3D bioprinters," said Keith Murphy, Chairman and Chief Executive Officer at Organovo. "This relationship will lead to advances in bioprinting, including both greater flexibility and throughput internally, and the potential long-term ability for customers to design their own 3D tissues for production by Organovo."

"Bioprinting has the potential to change the world," said Jeff Kowalski, Senior Vice President and Chief Technology Officer at Autodesk. "It's a blend of engineering, biology and 3D printing, which makes it a natural for Autodesk. I think working with Organovo to explore and evolve this emerging field will yield some fascinating and radical advances in medical research."



Posted in 3D Software

 

Maybe you also like:


 




Leave a comment:

Your Name: